Cargando…
Accelerated Cardiac Aging in Patients With Congenital Heart Disease
An increasing number of patients with congenital heart disease (CHD) survive into adulthood but develop long-term complications including heart failure (HF). Cellular senescence, classically defined as stable cell cycle arrest, is implicated in biological processes such as embryogenesis, wound heali...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9177956/ https://www.ncbi.nlm.nih.gov/pubmed/35694664 http://dx.doi.org/10.3389/fcvm.2022.892861 |
_version_ | 1784722951490240512 |
---|---|
author | Iacobazzi, Dominga Alvino, Valeria Vincenza Caputo, Massimo Madeddu, Paolo |
author_facet | Iacobazzi, Dominga Alvino, Valeria Vincenza Caputo, Massimo Madeddu, Paolo |
author_sort | Iacobazzi, Dominga |
collection | PubMed |
description | An increasing number of patients with congenital heart disease (CHD) survive into adulthood but develop long-term complications including heart failure (HF). Cellular senescence, classically defined as stable cell cycle arrest, is implicated in biological processes such as embryogenesis, wound healing, and aging. Senescent cells have a complex senescence-associated secretory phenotype (SASP), involving a range of pro-inflammatory factors with important paracrine and autocrine effects on cell and tissue biology. While senescence has been mainly considered as a cause of diseases in the adulthood, it may be also implicated in some of the poor outcomes seen in patients with complex CHD. We propose that patients with CHD suffer from multiple repeated stress from an early stage of the life, which wear out homeostatic mechanisms and cause premature cardiac aging, with this term referring to the time-related irreversible deterioration of the organ physiological functions and integrity. In this review article, we gathered evidence from the literature indicating that growing up with CHD leads to abnormal inflammatory response, loss of proteostasis, and precocious age in cardiac cells. Novel research on this topic may inspire new therapies preventing HF in adult CHD patients. |
format | Online Article Text |
id | pubmed-9177956 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-91779562022-06-10 Accelerated Cardiac Aging in Patients With Congenital Heart Disease Iacobazzi, Dominga Alvino, Valeria Vincenza Caputo, Massimo Madeddu, Paolo Front Cardiovasc Med Cardiovascular Medicine An increasing number of patients with congenital heart disease (CHD) survive into adulthood but develop long-term complications including heart failure (HF). Cellular senescence, classically defined as stable cell cycle arrest, is implicated in biological processes such as embryogenesis, wound healing, and aging. Senescent cells have a complex senescence-associated secretory phenotype (SASP), involving a range of pro-inflammatory factors with important paracrine and autocrine effects on cell and tissue biology. While senescence has been mainly considered as a cause of diseases in the adulthood, it may be also implicated in some of the poor outcomes seen in patients with complex CHD. We propose that patients with CHD suffer from multiple repeated stress from an early stage of the life, which wear out homeostatic mechanisms and cause premature cardiac aging, with this term referring to the time-related irreversible deterioration of the organ physiological functions and integrity. In this review article, we gathered evidence from the literature indicating that growing up with CHD leads to abnormal inflammatory response, loss of proteostasis, and precocious age in cardiac cells. Novel research on this topic may inspire new therapies preventing HF in adult CHD patients. Frontiers Media S.A. 2022-05-26 /pmc/articles/PMC9177956/ /pubmed/35694664 http://dx.doi.org/10.3389/fcvm.2022.892861 Text en Copyright © 2022 Iacobazzi, Alvino, Caputo and Madeddu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cardiovascular Medicine Iacobazzi, Dominga Alvino, Valeria Vincenza Caputo, Massimo Madeddu, Paolo Accelerated Cardiac Aging in Patients With Congenital Heart Disease |
title | Accelerated Cardiac Aging in Patients With Congenital Heart Disease |
title_full | Accelerated Cardiac Aging in Patients With Congenital Heart Disease |
title_fullStr | Accelerated Cardiac Aging in Patients With Congenital Heart Disease |
title_full_unstemmed | Accelerated Cardiac Aging in Patients With Congenital Heart Disease |
title_short | Accelerated Cardiac Aging in Patients With Congenital Heart Disease |
title_sort | accelerated cardiac aging in patients with congenital heart disease |
topic | Cardiovascular Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9177956/ https://www.ncbi.nlm.nih.gov/pubmed/35694664 http://dx.doi.org/10.3389/fcvm.2022.892861 |
work_keys_str_mv | AT iacobazzidominga acceleratedcardiacaginginpatientswithcongenitalheartdisease AT alvinovaleriavincenza acceleratedcardiacaginginpatientswithcongenitalheartdisease AT caputomassimo acceleratedcardiacaginginpatientswithcongenitalheartdisease AT madeddupaolo acceleratedcardiacaginginpatientswithcongenitalheartdisease |